Results update from the DRIVE PK study: Effects of AG-348, a pyruvate kinase activator, in patients with pyruvate kinase deficiency

Authors
Category Primary study
JournalTransfusion Medicine
Year 2018
This article has no abstract
Epistemonikos ID: 0667261ce488eb7ff450717840c1bd252f75a21e
First added on: Feb 09, 2025